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Summary: Type I collagen is the main type found in mineralized bone. Specific radioimmunoassay for the cross-
linked carboxyterminal telopeptide of type I collagen allows assessing the degradation of type I collagen in serum
samples.
The aim of the present investigation was to determine the concentration of cross-linked carboxyterminal
telopeptide of type I collagen in serum of dietary calcium and vitamin D-deficient rats, a good model disease
of decreased formation and mineralization of bone matrix and excessive bone resorption. The studies were
carried out on 20 young growing Wistar rats. Serum concentration of the cross-linked carboxyterminal telopep-
tide of type I collagen was analyzed by the Rat Telopeptide [125I]ICTP Radioimmunoassay Kit obtained from
Orion Diagnostica (Finland).
The data obtained from biochemical analysis showed increased concentration of the cross-linked carboxyterminal
telopeptide of type I collagen in the serum of rats fed a low calcium and vitamin D-deficient diet after 14 days of
the experiment. At the end of the experiment (day 21), the concentration of carboxyterminal telopeptide of type I
collagen in serum was still elevated in these animals.
In conclusion, dietary calcium and vitamin D-deficiency in rats produces hypocalcaemia together with the increased
concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum.
Introduction
Type I collagen is the most abundant form of collagen collagen. The telopeptide is liberated during degrada-
in bone, forming 90% of the organic matrix. It is synthe- tion of collagen fibrils of bone and can be estimated in
sized by osteoblasts and is formed as a large precursor blood samples (2, 3). Many diseases, e. g. rheumatoid
protein, type I procollagen (1, 2). In type I collagen of arthritis, multiple myeloma, bone metastases in pa-
bones part of the mature cross-links is formed from two tients suffering from cancer of the prostate, and os-
original hydroxylysine residues and one lysine residue teopenia among premature infants are associated with
(deoxypyridinoline) or from three hydroxylysine resi- increased degradation of type I collagen in the skeleton
dues (pyridinoline). The hydroxylysine residues can be (2, 6—8). Furthermore, long-term suppressive thyrox-
glycosylated. Similar structures occur in other collagen ine treatment in patients with thyroid carcinoma seems
types, particularly in the type II collagen of cartilage, to accelerate bone collagen degradation and carries a
which is rich in pyridinoline (3). When the collagen mat- risk of osteoporosis (9). Type I collagen telopeptide
rix is degraded, both kinds of cross-links are released concentration was also found to be correlated with
into the circulation and excreted in urine. Deoxypyridi- bone resorption rate, measured histomorphometrically
noline is found almost exclusively in bone, whereas pyr- (3, 8, 10).
idinoline is located in collagen fibrils of bone as well as fa ±Q experimental study performed on the rats fed a
cartilage. The measurements of deoxypyridinoline and bw caldum and vitamm D.deficient diet for 21 ̂
pyridinolme in urine are considered to be indices of the ^ increased resorptive processes concomitant with a
activity of bone collagen degradation (4, 5). defect ώ ±Q process Qf bone formation ̂  its ̂ ^
Another simple and quantitative test of type I collagen zation of the alveolar process in histologic examinations
degradation is based on the analysis of the concentra- were observed. Densitometric analysis showed the de-
tion of carboxyterminal telopeptide region of type I creased density of the whole bony system of these ani-
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mals and finally biochemical examinations showed hy-
pocalcaemia together with the increase in alkaline phos-
phatase activity (11).
The aim of the present investigation was to determine
serum concentration of the cross-linked carboxyterminal
telopeptide of type I collagen in rats fed a low calcium
and vitamin D-deficient diet.
Materials and Methods
Animals and diets
Young male Wistar rats (body weight 106 ± 3.6 g, 30 days old)
were the experimental animals. At the beginning of the experimen-
tal period, the rats were divided into two groups with 10 animals
in each group:
(1) control animals — group B — were fed a diet meeting the
nutritional needs of the rats (12 g/kg Ca, 2250 I.U./kg vitamin Da);
(2) test animals - group A - were fed a deficient diet (0.4 g/kg
Ca, no vitamin D), but otherwise equal to the diet fed the first
group.
The animals were allowed free access to water. The diet was based
on the original recipe made by Engstr m et al. (12).
Specimen collection and storage
Blood samples were drawn from each animal by intravenous punc-
ture of the jugular vein on days 14 and 21 of the experiment. Serum
samples were separated and stored at — 30 °C until they were as-
sayed. At the end of the experiment (day 21), the animals were
killed by exsanguination under anaesthesia with sodium barbital
(40 mg/kg intraperitoneal).
Determination of serum concentration of the cross-
linked carboxyterminal telopeptide of type I collagen
(ICTP)
Principles of the radioimmunoassay
Concentration of cross-linked carboxyterminal telopeptide of type I
collagen in serum was determined by radioimmunoassay (Rat-Telo-
peptide [125I]ICTP, Orion Diagnostica, Espoo, Finland). The rat
carboxyterminal telopeptide of type I collagen assay kit is based
on the widely known radioimmunoassay technique. This assay uses
the antigen-antibody reaction where the labelled and non-labelled
antigens compete for the limited number of high affinity binding
sites of the antibodies. The amount of radioactive antigen in the
antigen-antibody complex is inversely proportional to the amount
of non-labelled antigen in the reaction mixture. After the separation
of the free antigen from the antibody-antigen complex, the residual
radioactivity is counted and the actual concentration is calculated
with the aid of a standard curve based on the known amounts of
non-labelled antigen analyzed parallel to the unknown ones (ac-
cording to Orion Diagnostica Instruction Kit).
Procedure of the assay
Serum samples (25 μΐ) were mixed with 200 μΐ of RAT-ICTP anti-
serum and 200 μΐ of 125I-labelled RAT-ICTP. After a 2 hour incuba-
tion at 37 °C separation reagent was mixed thoroughly by gentle
inversion and then added. Tubes were allowed to stand for 30 min-
utes at room temperature and then were centrifuged for 30 minutes.
The supernatant was then removed and the sediment containing the
precipitated antibody-antigen complex was counted in a gamma
counter (according to Orion Diagnostica Instruction Kit).
In our laboratory, the intra-assay precision ranged from 2.8% to
6.2%; inter-assay precision ranged from 4.1% to 7.9%; the sensitiv-
ity of the assay was 0.5 μ^. The concentration of the cross-linked
carboxyterminal telopeptide of type I collagen in serum was ex-
pressed in μ .̂
Determination of total calcium concentration in serum
Total calcium concentration in sera of the rats from both groups
were determined by standard colorimetric methods using a Cobas
Mira analyzer, Hoffmann LaRoche (Switzerland).
Statistics
The data obtained from biochemical study were presented as the
arithmetical mean with the standard deviation (x ± SD) for each
group of 10 rats (n = 10). A comparison between the two groups
was performed with the unpaired Student's t test. Comparisons be-
tween the mean values of serum concentration of the cross-linked
carboxyterminal telopeptide of type I collagen obtained on days 14
and 21 of the experiment within one group were performed with
the paired Student's test. Statistically significant difference was
considered at p <0.05.
Results
The results of biochemical analysis of total calcium con-
centration in sera of the rats fed a low calcium and vita-
min D-deficient diet had been presented previously (6).
The mean value of total calcium concentration in sera
of the test animals obtained on day 14 was
1.84 ± 0.05 mmol/1, while in the control animals it was
2.51 ± 0.12 mmol/1. The differences between the values
were statistically significant (p < 0.001). On day 21, the
mean value of total calcium concentration in sera of the
test animals was 1.78 ±0.1 mmol/1 and was lower than
that obtained in the control rats - 2.53 ±0.11 mmol/
1. The differences between the values were statistically
significant (p < 0.001).
The concentration of the cross-linked carboxyterminal
telopeptide of type I collagen on days 14 and 21 of the
experiment are shown in table 1. The mean concentra-
tion of the cross-linked carboxyterminal telopeptide of
type I collagen in serum on day 14 was significantly
higher in the rats fed a low calcium and vitamin D-
deficient diet (p < 0.001) in comparison to the mean
value obtained in the control animals. At the end of the
experiment (day 21), the concentration of the carboxy-
terminal telopeptide of type I collagen in serum was still
Tab. 1 Mean values of serum carboxyterminal telopeptide of ty-
pe I collagen concentration in the test (group A) and the control
(group B) animals (days 14 and 21). Values are the mean with the
standard deviation (x ± SD) for the groups of 10 animals each
(n = 10)
Concentration of carboxyterminal
telopeptide of type I collagen











* p < 0.001 statistically significant difference between the mean
values obtained on days 14 and 21 of the study in test animals
(group A)
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elevated in the test animals (p <0.001) compared to the
mean value obtained in the control group. A statistically
significant difference (p < 0.001) was also found be-
tween the mean values of serum concentration of the
cross-linked carboxyterminal telopeptide of type I colla-
gen in the test animals obtained on days 14 and 21 of
the study.
Discussion
Bone remodelling first comprises a phase of osteoclast
activation and osteoclastic bone resorption with the for-
mation of a resorption cavity. Subsequently, osteoblasts
synthesize type I collagen. Then the osteoid matrix thus
formed undergoes mineralization and self-repair of skel-
etal tissue occurs (2). A dietary calcium and vitamin D-
deficiency in rats enhances osteoclastic bone resorption
concomitant with a defect in bone matrix formation and
its mineralization as observed in our previous histologic
examinations. We observed these morphological
changes in the alveolar process of the rat's maxilla since
this tissue is characterized by the high bone turnover
(11).
Type I collagen telopeptide concentration was found to
be correlated with cancellous bone resorption rate, mea-
sured by histomorphometry, and therefore is regarded as
a specific marker of bone resorption (8, 10).
Elomaa et al. (2) studied the serum concentration of
carboxyterminal propeptide of type I procollagen and
carboxyterminal telopeptide of type I collagen in order
to follow bone turnover and evaluate treatment response
in multiple myeloma, which is a good model disease
for excessive osteolysis. The study indicated that serum
concentration of carboxyterminal telopeptide of type I
collagen correlated with the number of osteolytic
lesions. The lack of correlation between carboxyterminal
telopeptide of type I collagen and carboxyterminal pro-
peptide of type I procollagen proves, in the authors'
opinion, imbalanced bone turnover and suggests un-
changed and even depressed bone formation in
multiple myeloma.
Eriksen at al. (10), using the method of calcium kinetics
and dynamic histomorphometry, found a significant cor-
relation between serum concentration of carboxytermi-
nal telopeptide of type I collagen and bone resorption in
patients with low and high bone turnover rates.
Mora et al. (8) stated that carboxyterminal telopeptide
of type I collagen is a useful marker of bone modelling
in osteopenia, a well-recognized disorder of bone metab-
olism among premature infants. The authors studied
bone formation and degradation through the measure-
ments of three indices: osteocalcin, carboxyterminal
propeptide of type I procollagen and carboxyterminal
telopeptide of type I collagen in premature infants at the
age of 4 weeks in comparison to full-term subjects. The
results showed significantly higher osteocalcin levels in
full-term infants, while the bone resorption marker, car-
boxyterminal telopeptide of type I collagen, was signifi-
cantly higher in premature infants than in full-term ones.
Carboxyterminal propeptide of type I procollagen did
not differ between the two groups. The authors conclude
that in premature infants at the age of 4 weeks, there
appeared a low osteoblastic activity and enhanced bone
degradation compared with that of full-term controls.
The imbalance of bone modelling could be the cause of
the reduced bone mineralization found in preterm in-
fants.
Hakala et al. (6) assessed the extent and clinical signifi-
cance of serum carboxyterminal telopeptide of type I
collagen in rheumatoid arthritis. It has been proven by
the authors that the elevated serum concentration of
carboxyterminal telopeptide of type I collagen is com-
mon in rheumatoid arthritis and associated with the
signs of aggressive disease.
To the contrary, Garnero et al. (13) performed studies on
a group consisting of late postmenopausal osteoporotic
women and found no statistically significant differences
in the values of serum concentration of carboxyterminal
telopeptide of type I collagen and carboxyterminal pro-
peptide of type I procollagen in comparison with the
group of controls, although other biochemical markers
of bone metabolism, e. g. serum total and serum intact
osteocalcin concentration, serum bone alkaline phospha-
tase activity and urinary total pyridinoline and deoxy-
pyridinoline, indicated increased bone turnover and, as
determined by dual energy X-ray absorptiometry
showed decreased bone mass. The authors explain that
a possible reason for inability of serum carboxyterminal
telopeptide of type I collagen to detect increase in bone
turnover is that the circulating carboxyterminal telopep-
tide of type I collagen may not reflect the true collagen
degradation rate, but may reflect other aspects of con-
nective tissue turnover. Delmas (14) suggests that serum
carboxyterminal telopeptide of type I collagen is an in-
dex of collagen turnover, but not a specific marker of
bone resorption.
The results of our study showed the increased values of
serum concentration of the cross-linked carboxyterminal
telopeptide of type I collagen in the rats fed a low
calcium and vitamin D-deficient diet in comparison to
the values obtained in the control animals. Considering
the morphological changes of the alveolar process of the
maxilla and densitometric data described previously (11)
we suggest that the elevated serum concentration of the
cross-linked carboxyterminal telopeptide of type I colla-
gen correlates with the increased bone resorption and
decreased density of the whole bony system in the rats
fed a low calcium and vitamin D-deficient diet. More-
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over, the elevated serum concentration of the cross-
linked carboxyterminal telopeptide of type I collagen
correlates with the decreased levels of total calcium in
sera of these animals.
In conclusion, dietary calcium and vitamin D-deficiency
in rats produces hypocalcaemia together with the
increased serum concentration of the cross-linked car-
boxyterminal telopeptide of type I collagen.
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